NASDAQ: AAPGAscentage Pharma Group International Revenue
Ascentage Pharma Group International revenue was $134.15M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AAPG annual revenue was $134.3M, with 329.1% growth year-over-year.
AAPG past revenue growth
How has AAPG's revenue growth performed historically?
Company
329.06%
Industry
1,361.15%
Market
34.96%
AAPG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AAPG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AAPG's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
AAPG revenue history
Current Revenue
$134.3M
Current Earnings
-$55.5M
Current Profit Margin
-41.3%
Be the first to know when AAPG announces revenue.
AAPG Revenue History By Year
| AAPG Yearly Revenue | AAPG Revenue | AAPG Change | AAPG Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $134.34M | $103.03M | +329.06% |
| 2023-12-31 | $31.31M | $1.22M | +4.06% |
| 2022-12-31 | $30.09M | N/A | N/A |
Ascentage Pharma Group International Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.